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Abstract 
 
Purpose:To prospectively compare diagnostic accuracy of fetal post-mortem whole-
body MRI at 3-Tvs.1.5-T. 
Methods:Between Oct-2012-Jul-2015, post-mortem MRI at 1.5-T and 3-T was 
performed in fetuses after miscarriage/stillbirth or termination. Clinical diagnoses made 
using MRI were assessed using a confidence diagnostic score and compared with 
classical autopsy to derive a diagnostic error score. The relation of diagnostic error for 
each organ group with gestational age was calculated and the comparison between 
1.5-T with 3-T. Accuracy analysis was used to compare 1.5-T with 3-T. 
 
Results:135 fetuses at 12-41 weeks underwent post-mortem MRI (followed by 
conventional autopsy in 92 fetuses). For all organ groups except the brain, and for both 
modalities, the diagnostic error decreased with gestation(p<0.0001). The 3-T MRI 
diagnostic error was significantly lower than that of 1.5-T for all anatomic structures 
and organ groups, except the orbits and brain. This difference was maintained for 
fetuses <20 weeks gestation. Moreover, 3-T was associated with fewer non-diagnostic 
scans and greater concordance with classical autopsy than 1.5-T MRI, especially for 
the thorax, heart and abdomen in fetuses<20 weeks.  
 
Conclusion:Post-mortem fetal 3-T MRI improves confidence scores and overall 
accuracy as compared with 1.5-T, mainly for the thorax, heart, and abdomen of fetuses 
<20 weeks of gestation. 
 
 
Word count: 200.  
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Key points:  
 
- In PM-MRI, diagnostic error using 3-T is lower than that with 1.5-T.  
 
- In PM-MRI, diagnostic scan rate is higher using 3-T than 1.5-T.  
 
- In PM-MRI, concordance with classical autopsy increases with 3-T.  
 
- PM-MRI using 3-T is particularly interesting for thoracic and abdominal organs.  
 
- PM-MRI using 3-T is particularly interesting for fetuses < 20 weeks’ gestation.  
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Introduction  
Technological advances in prenatal diagnostic tools have yielded the possibility of 
early diagnosis of fetal structural abnormalities, from the first trimester scan [1–3]. In 
the case of a severe abnormality, the parents often opt for termination of pregnancy 
and, in such circumstances as well as in the case of miscarriage, post-mortem 
examination by conventional autopsy remains critical for confirming or refuting the 
ante-mortem diagnosis and plays an important role in counseling parents concerning 
the recurrence risks for future pregnancies [4,5]. Unfortunately, perinatal autopsy rates 
are declining, reaching only 50% of eligible cases in some countries [6,7]. Factors 
associated with lack of parental consent include advanced gestational age at fetal 
death and religious considerations [8,9]. Furthermore, conventional autopsy might be 
difficult to perform in small fetuses at less than 20 weeks of gestation and calls for 
highly specialized fetal pathologists, who are often difficult to find [10].  
In the last decade, efforts have been made to develop less invasive methods of post-
mortem examination. Post-mortem magnetic resonance (MR) imaging is now 
suggested as an acceptable alternative to conventional autopsy and has a parental 
acceptance of 79-99% [8,9]. Recently, a prospective validation study for minimally 
invasive autopsy demonstrated a concordance of 89.3% with conventional autopsy 
[11]. This method included clinical history, external examination, post-mortem genetic 
and metabolic tests and post-mortem 1.5-T MR imaging. However, the concordance 
with autopsy for MR imaging alone was only 42.7% and 63%, respectively, for fetuses 
at ≤24 and > 24 weeks of gestation. 
MR imaging with a high-field magnet at 3-T has been developed for current clinical 
practice and its application has been studied in many medical fields [12,13]. However, 
few studies have considered its contribution to fetal post-mortem imaging [14–18] and 
we lack comparison with fetal whole-body post-mortem MR imaging at 1.5-T.   
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The aim of our study was therefore to compare the image quality and diagnostic 
accuracy of fetal post-mortem whole-body MR imaging at 3-T and 1.5-T. 
 
  
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
6 
 
Materials and methods 
 
Study participants and design 
The study was approved by the local ethics committee, and all written informed 
consent had been obtained from all parents. This was a single-institution prospective 
study, conducted at the Department of Radiology and Fetal Medicine Unit of the 
University Hospital ---, ---, ---, ---. Between October 2012 and July 2015, all consecutive 
patients suffering a fetal loss were invited to participate in this study whereby whole-
body post-mortem MR imaging with 1.5-T and 3-T was performed in addition to 
conventional autopsy. Fetal deaths were related to termination, miscarriage or stillbirth. 
The fetuses were stored in refrigerated compartments at 4 °C before MR imaging 
examination.  
MR imaging examination  
As soon as possible after delivery, and in a random order, consecutive whole-body MR 
imaging was performed using a 1.5-T magnet (Siemens Magnetom Avanto, Erlangen, 
Germany) and a 3-T magnet (Philips Achieva, Best, Netherlands).  
Axial views of the head, and axial and coronal views of the body were acquired with 
high-resolution T2-weighted sequences. The parameters were adapted to obtain the 
best image quality within a maximum acquisition time of 60 minutes as we estimated 
that a longer acquisition time would be difficult to implement in future clinical practice. 
In this way, we hoped to reach the maximum capacity for both machines to allow the 
most equitable comparison. The typical acquisition parameters of the MR imaging 
protocols on both magnets are summarized in Table 1.  
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Image evaluation 
Image contrast was evaluated for all cases by measuring the mean signal intensity in 
16 anatomic areas with Image J (Version 1.46, National Institute of Health, US) by a 
single operator (first author) [10]: grey matter, thalamus, white matter, cartilage (head 
of humerus), bone (humeral diaphysis), muscle, intracardiac blood pool, myocardium, 
pericardial effusion, pleural effusion, lung, liver, adrenals, renal cortex, renal pelvis and 
spleen. Tissue contrast was calculated for 14 regions of interest (ROIs) with the 
previously published formula [10]:  
𝑆𝑖𝑔𝑛𝑎𝑙 𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 𝑜𝑓 𝑎𝑟𝑒𝑎 𝐴 − 𝑆𝑖𝑔𝑛𝑎𝑙 𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 𝑜𝑓 𝑎𝑟𝑒𝑎 𝐵
𝑆𝑖𝑔𝑛𝑎𝑙 𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 𝑜𝑓 𝑎𝑟𝑒𝑎 𝐴 + 𝑆𝑖𝑔𝑛𝑎𝑙 𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 𝑜𝑓 𝑎𝑟𝑒𝑎 𝐵
 
 The clinical diagnoses of all cases were assessed independently by two radiologists 
(2nd and 3rd author, both with more than 10 years of experience in post-mortem MR 
imaging, at the start of the study). The 2 radiologists were blinded to the magnet used 
(1.5-T vs. 3-T), the results of the prenatal ultrasound examination, the other reader’s 
report and the results of the conventional autopsy. The images obtained from both MR 
imaging machines were mixed and then presented in a random order.  
A previously published confidence diagnostic score from 0 to 100 was given for 29 
anatomic structures (0 definitely abnormal, 1-49 probably abnormal, 50 non-
diagnostic, 51-99 probably normal and 100 definitely normal) [8]. In the case of 
concordance between operators, the mean score of the two operators was then 
calculated. In the case of discordance between operators, a consensus was reached 
and a new score was given. Abnormalities recognized as post-mortem changes were 
scored as normal. 
Post-mortem examination 
As soon as possible after the post-mortem MR imaging, conventional autopsy was 
performed by two pathologists with more than 15 years of experience in fetal autopsy. 
According to current clinical practice, the pathologists were informed about the main 
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prenatal findings related to fetal death in order to produce a full clinical report allowing 
counselling parents about their recurrence. The pathologists were blinded to the MR 
imaging examination results. The autopsy data were entered into a database that was 
separated from that used for the MR imaging examinations. The autopsy results were 
converted to the previously described diagnostic score for the same 29 anatomic 
structures analyzed with post-mortem MR imaging (0=abnormal, 50=non diagnostic 
and 100=normal). 
 
Sample size 
Based on published data on the ability to visualize the four-chamber view of fetuses at 
< 20 weeks of gestation with post-mortem fetal MR imaging with 3-T and 1.5-T(16), a 
power analysis performed before data collection revealed that at least 76 fetuses 
would be needed to detect a 5% difference in the number of visualized four-chamber 
views between the 2 modalities, with 95% power. Given that these data described only 
the visualization of the four-chamber view of fetuses at < 20 weeks of gestation, we 
increased the sample size to more than 90 cases with full autopsy.  
 
Statistical analysis 
The diagnostic error at MR imaging was defined and calculated as the absolute value 
of the difference between the autopsy, when available, and MR imaging diagnostic 
score as represented by the following formula: 
Diagnostic error =│Autopsy diagnostic score – MR imaging diagnostic score│ 
 
The anatomic structures were then grouped to calculate the mean diagnostic error for 
the brain (5 anatomic structures), the face (3 anatomic structures), the thorax (3 
anatomic structures), the heart (7 anatomic structures), the abdomen (8 anatomic 
structures) and the skeleton (3 anatomic structures).  
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The proportion of non-diagnostic cases at classical autopsy for the brain as compared 
with other organs was compared using Mc Nemar’s test of proportion for paired 
samples. The tissue contrasts of the 14 ROIs were compared for 1.5-T and 3-T with 
the Wilcoxon test for paired samples.  
 
The diagnostic errors for each organ group and gestational age were correlated using 
Spearman correlation analysis. Diagnostic errors for each anatomic structure and 
organ group were compared for 1.5-T and 3-T with the Wilcoxon test for paired 
samples.  
 
For the accuracy analysis, the mean diagnostic score of post-mortem MR imaging and 
classical autopsy for each anatomic structure was transformed into categorical data as 
follows: 0-49 abnormal, 50 non-diagnostic, and 51-100 normal. When one anatomic 
structure was diagnosed as abnormal, the whole organ group was considered 
abnormal. When one anatomic structure was non-diagnostic and the other structures 
were normal, the organ group was considered non-diagnostic. When every structure 
was normal, the organ group was considered normal. The autopsy findings are set as 
the reference standard for comparison. We included the non-diagnostic cases in the 
group of false negatives for calculation of sensitivity and in the group of false positives 
for calculation of specificity.  
 
Concordance was defined as the sum of true positives and true negatives divided by 
all cases including non-diagnostic cases. Discordance was defined as the sum of false 
negatives and false positives divided by all cases including non-diagnostic cases. The 
accuracy tests were compared with McNemar’s test of proportion for paired samples. 
Post-hoc analyses were conducted for sensitivity and specificity comparison when the 
difference between 3-T and 1.5-T was no significant for thoracic, cardiac and 
abdominal organs in fetuses < 20 weeks. 
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Data are presented as medians unless mentioned otherwise. Data were analyzed with 
the statistical software packages STATA, version 12.0 (StataCorp LP, Texas) and 
Excel, version 9.0 (Microsoft, Redmond, WA). Post-hoc analysis for power and sample 
size was performed with R version 3.0.2 (The R Foundation for Statistical Computing, 
Vienna, Austria). Two-sided P<0.05 was considered statistically significant.  
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Results 
 
During the study period, 195 consecutive fetal losses occurred in our center but 135 
fetuses were included in the study with post-mortem MR imaging performed 0-5 days 
after delivery and classical autopsy, when consent was obtained, 1-7 days after 
delivery (Fig 1). The median gestational age was 25.0 (range, 12.0-41.1) weeks. There 
were 44 fetuses of gestational age < 20 weeks and 91 ≥ 20 weeks. For 92 of the 135 
(68.1%) fetuses included, the parents consented to classical whole-body post-mortem, 
with 32 at < 20 and 60 at ≥ 20 weeks of gestation. Of the 135 fetuses, 88 (65.2%) had 
known prenatal abnormalities, 43 (31.8%) had normal prenatal ultrasound imaging 
data and 4 (3.0%) had no prenatal imaging. There was disagreement between readers 
in 12 (4.4 %) out of 270 MR examination for which a consensus view was obtained. 
 
The study flowchart and the diagnosis of each organ group with post-mortem MR 
imaging at 1.5-T and 3-T and classical autopsy are summarized in Fig 1. The 
proportion of non-diagnostic cases at classical autopsy was significantly higher for the 
brain with 39 out of 92 cases (42.4%), as compared with the face, 6 (6.5%), thorax, 4 
(4.3%), heart, 6 (6.5%), abdomen, 1 (1.1%) and skeleton, 4 (4.3%) (p<0.0001 for all). 
Among the non-diagnostic cases at classical autopsy for the brain, 32 of 39 (82.1%) 
were diagnostic with 1.5-T and 31 (79.5%) with 3-T.  
 
Tissue contrast was significantly increased with 3-T as compared with 1.5-T MR 
imaging for 9 out of the 14 studied ROI (Fig 2, and Fig 3-online).  
 
For all organ groups except the brain, and for both modalities (1.5-T and 3-T), the 
diagnostic error and gestational age showed significant inverse correlation (p<0.0001 
for all) (Fig 4).   
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The diagnostic error was lower for 3-T than for 1.5-T MR imaging for all anatomic 
structures and organ groups, with the exception of the orbits and all structures of the 
brain (Table 2). This difference remained significant for fetuses at < 20 weeks and ≥ 
20 weeks of gestation, except for the face, for which the difference became non-
significant at ≥ 20 weeks of gestation (Fig 5).   
 
Diagnostic accuracy for 3-T and 1.5-T MR imaging for all dataset and for each organ 
group are illustrated in Table 3. Overall, 3-T showed fewer non-diagnostic scans 
allowing an increase in sensitivity, specificity and concordance rate than 1.5-T MR 
imaging, and these differences are mainly present in fetuses < 20 weeks (p<0.01 for 
all). (Fig 3,6-8).    
 
In subgroups analysis by organ groups, there were fewer non-diagnostic scans at 3-T 
than 1.5-T of the face, thorax, heart and abdomen (p<0.05). This reduction of non-
diagnostic scans was significant for the face, thorax, heart and abdomen for fetuses < 
20 weeks (p<0.05) (Fig 6), whereas for fetuses ≥ 20 weeks, this reduction remained 
significant only for non-diagnostic abdominal scans (p<0.05). The proportion of 
concordant diagnoses also increased for 3-T MR imaging for the thorax, heart and 
abdomen, mainly for fetuses aged < 20 weeks (p<0.05 for all), but not for those ≥ 20 
weeks. No significant differences were seen in sensitivity in this subgroup analysis, 
irrespective of gestational age group. 
 
Post hoc power analysis with 80% power showed that to detect a significant difference 
in sensitivity between MR imaging at 1.5-T vs. 3-T in the group of fetuses < 20 weeks, 
61 with thoracic abnormalities, 32 with cardiac abnormalities and 45 with abdominal 
abnormalities would be needed. In this same group, to detect a significant difference 
in specificity between MR imaging at 1.5-T vs. 3-T, 33 fetuses with normal thorax and 
35 with normal abdomen are needed.  
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Discussion 
 
Our study shows that 3-T had better image contrast, fewer non-diagnostic 
examinations, lower diagnostic error, and higher sensitivity, specificity and 
concordance than 1.5-T for fetal post-mortem whole-body MR imaging. The 
improvement is mainly in fetuses below 20 weeks of gestational age, in particular for 
thoracic organs including the heart and abdominal organs, but not the brain.   
 
Since a higher field strength is accompanied by an increase in signal-to-noise ratio, 
better spatial resolution and thus more detailed imaging of fetal anatomy, attempts to 
improve image quality and diagnostic accuracy for small fetuses have focused on the 
use of higher-field magnets such as 3-T or 9.4-T [10,16–18]. In a study focusing on 
congenital heart defects (CHDs) including 24 fetuses at 11 to 20 weeks of gestation, 
MR imaging was performed with 1.5-T, 3-T and 9.4-T magnets prior to classical 
autopsy [16]. While only the cardiac situs and four-chamber view could be visualized 
in 62% and 25% of cases for 1.5-T MR imaging and 70% and 45% of cases on 3-T 
MR imaging respectively when the fetus was below 20 weeks of gestation, using MR 
imaging at 9.4 T, the cardiac situs, four-chamber view and the outflow tracts could be 
visualized in all fetuses irrespective of gestational age.  
 
The major limitation of using MR imaging at 9.4-T is that such machines are currently 
only available in research units and have no other clinical application, thus limiting their 
use for post-mortem examination. In contrast, 3-T magnets are widely available in 
radiology and other clinical imaging units. A retrospective study including 58 fetal 
prenatal MR imaging examinations showed an overall advantage of 3-T for antenatal 
fetal imaging, with higher imaging scores for 3-T vs. 1.5-T MR imaging across different 
fetal anatomic structures [19]. However, while safety concerns may arise prenatally 
[20], there are none for post-mortem examination.  
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Other fetal post-mortem imaging methods have been studied such as post-mortem 
ultrasound and post-mortem computerized tomography with or without contrast 
product for angiography. Post-mortem computerized tomography without contrast 
product has poor detection rate for major pathology in comparison to MR imaging [21]. 
Post-mortem computerized tomography angiography has shown promising results in 
feasibility studies [22,23], however validity studies are still needed. Ultrasound is a low-
cost and easily accessible imaging method. Its application in fetal post-mortem 
examination has been suggested by recent pilot studies [24]. However, the 
sonographer was not blinded to the antenatal diagnosis and more studies are still 
needed.  
The improvement of diagnostic accuracy with MR imaging at 3-T for cardiac 
abnormalities was suggested by Sandaite et al. in a retrospective study of 24 fetuses 
with CHDs assessed by post-mortem MR at 3-T at a median gestational age of 
22.2 (range 12.5-34.6) weeks including 10 fetuses below 20 weeks. 3-T MR imaging 
was diagnostic for 12 / 13 (92.3%) complex CHDs and for 6 / 11 (54.5%) isolated CHDs 
[18]. Regarding fetuses < 20 weeks, 3-T MR imaging was diagnostic in 50% of cases. 
The authors concluded that the technique was a valid diagnostic tool for CHDs in 
fetuses beyond 16 weeks of gestation.  
 
Our study has prospectively and blindly evaluated the contribution of 3-T in whole-
body post-mortem examination in comparison to 1.5-T MR imaging. We showed that 
3-T has fewer non-diagnostic scans, better image contrast, lesser diagnosis error and 
better overall accuracy in comparison to 1.5-T MR imaging. The impact of 3-T is more 
relevant for fetuses < 20 weeks. Regarding the heart, our study included 61 normal 
fetal hearts (14 fetuses <20 weeks) and 25 CHDs (13 fetuses < 20 weeks). For the 
subgroup of fetuses <20 weeks, 3-T MR imaging had 37.0 % of non-diagnostic scans, 
a specificity of 78.6% and a concordance rate of 55.6% with classical post-mortem 
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whereas 1.5-T imaging had 92.6% of non-diagnostic scans inducing 0% of 
concordance rate with classical post-mortem.   
 
Our data did not demonstrate an improvement in brain imaging at 3-T over 1.5-T since 
tissue contrast, diagnostic error and diagnostic accuracy were comparable with both 
modalities. 1.5-T MRI has been shown to have sufficient image quality for most major 
brain abnormalities [25]. Furthermore, there are very few non-diagnostic scans for the 
brain with either 3-T and 1.5-T magnets, even when classical autopsy fails to provide 
a diagnosis because of marked autolysis [8]. These results encourage future use of 
post-mortem MR imaging as a first-line diagnostic tool in fetal brain malformations [11]. 
In our study using 3-T magnets, diagnostic accuracy for dysmorphologic features of 
the face was not significantly improved, but the diagnostic error was decreased. 
Dysmorphologic features are easily noted on non-invasive external examination of the 
body and do not typically require imaging.   
 
Our data show similar sensitivity and specificity values for 1.5-T as compared with 
published data for the brain, thorax and musculoskeletal structures [25-27]. However, 
the sensitivity and specificity of abdominal structures at 1.5-T was lower in our study 
[28]. The large number of small fetuses included in our study could explain these 
results. Additionally, we included in our protocol analysis of the pancreas, which is 
often autolysed and therefore non-diagnostic, thus explaining the large number of non-
diagnostic abdominal scans in our study.  
 
We acknowledge that our study has some limitations. First, although our data include 
a large number of abnormalities, the sample size is not sufficient to demonstrate a 
significant difference in sensitivity between 3-T and 1.5-T for specific organs. For this 
purpose, the required number of cases with abnormalities per specific organ needs to 
be relatively high and can only be achieved in multicenter studies. Second, in our post-
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mortem evaluation we did not include clinical history, external examination, or post-
mortem genetic and metabolic tests, but only MR imaging, which led to 
underestimation of performance of a complete minimally invasive post-mortem using 
3-T. On the other hand, our purpose was to focus on improving the contribution of MR 
imaging alone since the rest of investigation can be done equally with both modalities.  
 
In conclusion, whole body post-mortem fetal MR imaging at 3-T has improved 
diagnostic accuracy compared to 1.5-T, mainly for fetuses < 20 weeks, particularly for 
thoracic and abdominal organs. However, the diagnostic performance of MR imaging 
alone at 3-T for fetuses below 20 weeks of gestation may be considered insufficient 
for clinical practice, so the search for alternative techniques in this particular group is 
still justified.   
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Table 1. Typical acquisition parameters of T2-weighted turbo spin-echo MR images of 
the fetus on the 1.5 T and 3.0 T magnets. Saline bags were used to enhance the signal 
level, for the most part for smaller fetuses. Very small fetuses of gestational age less 
than 14 weeks were imaged in a 60 cc syringe with saline solution. 
 
 
 
 
  
 1.5 T MRI 3.0 T MRI 
Coil  For small fetuses 4-ch flex coil, 
otherwise a body coil 
For small fetuses, an 8-ch 
SENSE wrist coil,  
otherwise a body coil 
Number of slices 25-111  48-240 
Slice thickness (mm) 2.0 1.2 
Intersection gap (mm) 0 0 
FOV (mm²) 280x210 to 360x280 160x128 to 350x280  
Matrix 350x420 to 450x560 320x213 to 700x467 
Effective echo time (ms) 98 to 121 80 
Repetition time (ms) 6400 to 14830 4821 to 10607 
Fourier Factor 1 1 
Voxel resolution (mm³)  0.8 x 0.5 x 2.0 0.5 x 0.6 x 1.2 
Bandwidth (Hz/pixel)  130 223 to 260 
Acquisition time (min) ≤ 60 ≤ 60  
NSA (NEX) 2 to 11 3 to 9  
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Table 2. Comparison of the median of the diagnostic error between 1.5-T and 3-T post-
mortem MR imaging.  
 
  
Median diagnosis error (n=92) 
  
Anatomic structure 3-T (p25-p75) 1.5-T (p25-p75) P value 
Corpus callosum 10 (0-27.5) 10 (5-20) 0.8857 
Thalamus 17.5 (7.5-35) 15 (7.5-35) 0.6086 
Ventricles 20(7.5-40) 17.5 (5-40) 0.7791 
Cortex 22.5(7.5-45) 20(7.5-40) 0.6928 
Cerebellum 15 (7.5-30) 17.5 (7.5-35) 0.1253 
Brain  21.5 (11-31.5) 20.5 (9-32) 0.9211 
Orbits 17.5 (7.5-50) 20 (10-50) 0.4796 
Posterior nasal apertures 12.5 (7.5-30) 15 (10-40) 0.0024 
Palate 15 (10-30) 17.5 (12.5-32.25) 0.0001 
Face 19.17 (10-36.67) 25 (11.67-39.17) 0.0005 
Trachea 10 (5-25) 12.5 (6.25-32.25) <0.0001 
Thymus 12.5 (5-30) 15 (10-37.5) 0.0003 
Lung 10 (5-20) 12.5 (5-26.25) <0.0001 
Thorax 10.83 (6.67-27.92) 14.58 (8.33-43.33) <0.0001 
Cardiac ventricles 20 (10-35) 25 (15-45) 0.0002 
Atria 20 (10-32.5) 25 (15-45) <0.0001 
Cardiac septum 15 (6.25-28.75) 21.25 (11.25-41.25) 0.0001 
Aorta 17.5 (7.5-28.75) 25 (13.75-45) <0.0001 
Pulmonary artery 17.5 (7.5-35) 25 (13.75-50) <0.0001 
Systemic veins 17.5 (5-28.75) 20 (10-45) <0.0001 
Pulmonary veins 21.25(7.5-40) 32.5(17.5-50) <0.0001 
Heart 20 ( 9.29-35.18) 26.25 (14.82-43.21) <0.0001 
Liver 10 (7.55-25) 15 (10-27.5) 0.0003 
Spleen 10 (5-25) 12.5 (7.5-33.75) <0.0001 
Pancreas 31.25 (17.5-50) 45(30-50) <0.0001 
Gallbladder 15 (7.5-30) 18.75 (12.5-40) <0.0001 
Bowels 10 (5-25) 15 (6.25-33.75) 0.006 
Adrenals 10 (10-25) 15 (10-30) <0.0001 
Kidneys 10 (5-25) 12.5 (7.5-32.5) 0.0003 
Bladder 11.25 (6.25-25) 15 (7.5-35) <0.0001 
Genitals 10 (5-40) 13.75 (7.5-50) 0.0016 
Abdomen 19.44 (10.42-29.58) 22.64 (13.33-36.25) <0.0001 
Spine 12.5 (7.5-25) 15 (10-30) <0.0001 
Vertebra 10 (5-22.5) 12.5 (7.5-30) 0.0016 
Musculoskeletal system 10 (7.5-30) 15 (7.5-40) 0.0117 
Skeleton 11.67 (4.5-33.33) 16.67 (9.17-35.83) 0.0001 
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Table 3. (ONLINE) Accuracy test comparison between 1.5-T and 3-T post-mortem MR imaging. * Exact 
C.I. 
  Overall < 20 weeks   
  3.0-T 1.5-T  p 3.0-T 1.5-T p 3.0-T  1.5-T p 
All organs                   
Non-diagnostic (%) 
10.0 (49/492) 
[7.3-12.6] 
20.3 (100/492) 
[16.8-23.9] 
<0.0001 
30.4 (48/158) 
[23.2-37.6] 
53.8 (85/158) 
[46.0-61.6] 
<0.0001 
0.3 (1/334)  
[0-0.9] 
4.5 (15/334)  
[2.3-6.7] 
0.0005 
Sensitivity (%) 
51.7 (74/143) 
[43.6-59.9] 
45.5 (65/143) 
[37.3-53.6] 
0.0225 
34.6 (18/52) 
[21.7-47.6] 
17.3 (9/52)  
[7.0-27.6] 
0.0039 
61.5 (56/91) 
[51.5-71.5] 
61.5 (56/91)  
[51.5-71.5] 
1 
Specificity (%) 
87.4 (305/349) 
[83.9-90.9] 
77.9 (272/349) 
[73.6-82.3] 
<0.0001 
65.1 (69/106) 
[56.0-74.2] 
45.3 (48/106) 
[35.8-54.8] 
<0.0001 
97.1 (236/243) 
[95.0-99.2] 
92.2 (224/243) 
[88.8-95.6] 
0.0018 
Concordant (%) 
77.0 (379/492) 
[73.3-80.8] 
68.5 (337/492) 
[64.4-72.6] 
<0.0001 
55.1 (87/158) 
[47.3-62.8] 
36.1 (57/158) 
[28.6-43.6] 
<0.0001 
87.4 (292/334) 
[83.9-91.0] 
83.8 (280/334) 
[79.9-87.8] 
0.0118 
Discordant (%) 
13.0 (64/492) 
[10.0-16.0] 
11.2 (56/492) 
[8.4-14.0] 
0.0784 
14.6 (23/158) 
[9.1-20.1] 
10.1 (16/158)  
[5.4-14.8] 
0.0923 
12.3 (41/334) 
[8.8-15.8] 
12.0 (40/334)  
[8.5-15.5] 
1 
Brain                   
Non-diagnostic (%) 
5.6 (3/53)  
[1.2-15.7]* 
5.6 (3/53) 
[1.2-15.7]* 
1 
18.8 (3/16) 
[4.1-45.7]* 
18.8 (3/16)  
[4.1-45.7]* 
1 
0 (0/37)  
[0-9.5] 
0 (0/37)  
[0-9.5] 
1 
Sensitivity (%) 
83.3 (15/18) 
[58.6-96.4]* 
83.3 (15/18) 
[58.6-96.4]* 
1 
100 (2/2)  
[15.8-100]* 
100 (2/2)  
[15.8-100]* 
1 
81.3 (13/16) 
[54.4-96.0]* 
81.3 (13/16) 
[54.4-96.0]* 
1 
Specificity (%) 
80 (28/35)  
[63.1-91.6]* 
85.7 (30/35) 
[69.7-95.2]* 
0.5 
50 (7/14)  
[23.0-77.0]* 
64.3 (9/14) 
[35.1-87.2]* 
0.5 
100 (21/21) 
[83.9-100]* 
100 (21/21)  
[83.9-100]* 
1 
Concordant (%) 
81.1 (43/53) 
[68.0-90.6]* 
84.9 (45/53) 
[72.4-93.3]* 
0.5 
56.3 (9/16) 
[29.9-80.3]* 
68.8 (11/16) 
[41.3-89.0]* 
0.5 
91.9 (34/37) 
[78.1-98.3]* 
91.9 (34/37) 
[78.1-98.3]* 
1 
Discordant (%) 
13.2 (7/53)  
[5.5-25.3]* 
9.4 (5/53) 
[3.1-20.7]* 
0.5 
25 (4/16)  
[7.3-52.4]* 
12.5 (2/16)  
[1.6-38.4]* 
0.5 
8.1 (3/37)  
[1.7-21.9]* 
8.1 (3/37)  
[1.7-21.9]* 
1 
Face                   
Non-diagnostic (%) 
5.8 (5/86)  
[1.9-13.1]* 
14.0 (12/86) 
[6.6-21.3] 
0.0156 
17.9 (5/28) 
[6.1-36.9]* 
39.3 (11/28) 
[21.2-57.4] 
0.0313 
0 (0/58)  
[0-6.2] 
1.7 (1/58)  
[0.0-9.2]* 
1 
Sensitivity (%) 
26.9 (7/26) 
[11.6-47.8]* 
19.2 (5/26) 
[6.6-39.4]* 
0.625 
22.2 (2/9) 
[2.8-60.0]* 
0 (0/9)  
[0-33.6] 
0.5 
29.4 (5/17) 
[10.3-56.0]* 
29.4 (5/17) 
[10.3-56.0]* 
1 
Specificity (%) 
95 (57/60)  
[86.1-99.0]* 
88.3 (53/60) 
[77.4-95.2]* 
0.125 
84.2 (16/9) 
[60.4-96.6]* 
73.7 (14/19) 
[48.8-90.9]* 
0.5 
97.6 (40/41) 
[87.1-99.9]* 
95.1 (39/41) 
[83.5-99.4]* 
1 
Concordant (%) 
73.3 (63/86) 
[65.2-83.6] 
67.4 (58/86) 
[57.5-77.4] 
0.125 
64.3 (18/28) 
[44.1-81.4]* 
50 (14/28) 
[31.5-68.5] 
0.1 
77.6 (45/58) 
[66.9-88.3] 
75.9 (44/58) 
[64.9-86.9] 
1 
Discordant (%) 
20.9 (18/86) 
[12.9-31.1] 
18.6 (16/86) 
[10.4-26.8] 
0.625 
17.9 (5/28) 
[6.1-36.9]* 
10.7 (3/28) 
[2.3-28.2]* 
0.5 
22.4 (13/58) 
[11.7-33.2] 
24.1 (14/58) 
[13.1-35.2] 
1 
Thorax                   
Non-diagnostic (%) 
10.2 (9/88)  
[4.8-18.5]* 
20.4 (18/88) 
[12.0-28.9] 
0.0117 
32.1 (9/28) 
[15.9-52.4]* 
60.7 (17/28) 
[42.6-78.8] 
0.0215 
0 (0/60)  
[0-6.0] 
1.7 (1/60)  
[0.0-8.9]* 
1 
Sensitivity (%) 
44.4 (8/18) 
[21.5-69.2]* 
33.3 (6/18) 
[13.3-59.0]* 
0.5 
12.5 (1/8) 
[0.3-52.7]* 
0 (0/8)  
[0-36.9] 
1 
70 (7/10)  
[34.8-93.3]* 
60 (6/10)  
[26.2-87.8]* 
1 
Specificity (%) 
90 (63/70)  
[80.5-95.9]* 
81.4 (57/70) 
[72.3-90.5] 
0.07 
70 (14/20) 
[45.7-88.1]* 
40 (8/20) 
[19.2-64.0]* 
0.07 
98 (49/50)  
[89.4-100]* 
98 (49/50) 
[89.4-100]* 
1 
Concordant (%) 
80.7 (71/88) 
[72.4-88.9] 
81.6 (83/88) 
[62.2-81.0] 
0.0215 
53.6 (15/28) 
[35.1-72.0] 
28.6 (8/28) 
[13.2-48.7]* 
0.0391 
93.3 (56/60) 
[83.8-98.2]* 
91.7 (55/60) 
[81.6-97.2]* 
1 
Discordant (%) 
9.1 (8/88)  
[4.0-17.1]* 
8.0 (7/88) 
[3.3-15.7]* 
1 
14.3 (4/28) 
[4.0-32.7]* 
10.7 (3/28) 
[2.3-28.2]* 
1 
6.7 (4/60)  
[1.9-16.2]* 
6.7 (4/60)  
[1.9-16.2]* 
1 
Heart                  
Non-diagnostic (%) 
11.6 (10/86) 
[5.7-20.4]* 
33.7 (29/86) 
[23.7-43.7] 
<0.0001 
37.0 (10/27) 
[19.4-57.6]* 
92.6 (25/27) 
[75.7-99.1]* 
0.0001 
0 (0/59)  
[0-6.1] 
6.8 (4/59)  
[1.9-16.5]* 
0.125 
Sensitivity (%) 
48 (12/25)  
[28.4-67.6] 
36 (9/25) 
[18.0-57.5]* 
0.375 
23.1 (3/13) 
[5.0-53.8]* 
0 (0/13)  
[0-24.7] 
0.3 
75 (9/12)  
[42.8-94.5]* 
75 (9/12)  
[42.8-94.5]* 
1 
Specificity (%) 
95.1 (58/61) 
[86.3-99.0]* 
70.5 (43/61) 
[59.1-81.9] 
0.0001 
78.6 (11/14) 
[49.2-95.3]* 
0 (0/14)  
[0-23.2] 
0.001 
100 (47/47) 
[92.5-100]* 
91.5 (43/47) 
[79.6-97.6]* 
0.125 
Concordant (%) 
81.4 (70/86) 
[73.2-89.6] 
60.5 (52/86) 
[50.1-70.8] 
<0.0001 
51.9 (14/27) 
[33.0-70.7] 
0 (0/27)  
[0-12.8] 
0.0001 
94.9 (56/59) 
[85.9-98.9]* 
88.1 (52/59) 
[77.1-95.1]* 
0.2188 
Discordant (%) 
7.0 (6/86)  
[2.6-14.6]* 
5.8 (5/86) 
[1.9-13.1]* 
1 
11.1 (3/27) 
[2.4-29.2]* 
7.4 (2/27) 
[0.9-24.3]* 
1 
5.1 (3/59)  
[1.1-14.2]* 
5.1 (3/59)  
[1.1-14.2]* 
1 
Abdomen                 
Non-diagnostic (%) 
17.6 (16/91) 
[9.8-25.4] 
36.3 (33/91) 
[26.4-46.1] 
0.0001 
48.4 (15/31) 
[30.8-66.0] 
77.4 (24/31) 
[58.9-90.4]* 
0.0039 
1.7 (1/60)  
[0.0-8.9]* 
15 (9/60)  
[7.1-26.6]* 
0.0215 
Sensitivity (%) 
56.3 (18/32) 
[39.1-73.4] 
53.1 (17/32) 
[35.8-70.4] 
1 
50 (6/12) 
[21.1-78.9]* 
33.3 (4/12) 
[9.9-65.1]* 
0.5 
60 (12/20)  
[38.5-81.5] 
65 (13/20) 
[40.8-84.6]* 
1 
Specificity (%) 
72.9 (43/59) 
[61.5-84.2] 
54.2 (32/59) 
[41.5-97.0] 
0.0034 
31.6 (6/19) 
[12.6-56.6]* 
10.5 (2/19) 
[1.3-33.1]* 
0.1 
92.5 (37/40) 
[79.6-98.4]* 
75 (30/40) 
[58.8-87.3}* 
0.0391 
Concordant (%) 
67.0 (61/91) 
[7.4-76.7] 
53.8 (49/91) 
[43.6-64.1] 
0.0042 
38.7 (12/31) 
[21.6-55.9] 
19.4 (6/31) 
[7.5-37.5]* 
0.0313 
81.7 (49/60) 
[71.9-91.5] 
71.7 (43/60) 
[60.3-83.1] 
0.1 
Discordant (%) 
15.4 (14/91) 
[8.0-22.8] 
9.9 (9/91) 
[4.6-18.0] 
0.0625 
12.9 (4/31) 
[3.6-29.8]* 
3.2 (1/31) 
[0.1-16.7]* 
0.3 
16.7 (10/60) 
[8.3-28.5]* 
13.3 (8/60)  
[5.9-24.6]* 
0.5 
Skeleton                  
Non-diagnostic (%) 
6.8 (6/88)  
[2.5-14.3]* 
5.7 (5/88) 
[1.9-12.8]* 
1 
21.4 (6/28) 
[8.3-41.0]* 
17.9 (5/28) 
[6.1-36.9] 
1 
0 (0/60)  
[0-6.0] 
0 (0/60)  
[0-6.0] 
1 
Sensitivity (%) 
58.3 (14/24) 
[36.6-77.9]* 
54.2 (13/24) 
[34.3-74.1] 
1 
50 (4/8) 
[15.7-84.3]* 
37.5 (3/8) 
[8.5-75.5]* 
1 
62.5 (10/16) 
[35.4-84.8]* 
62.5 (10/16) 
[35.4-84.8]* 
1 
Specificity (%) 
89.1 (57/64) 
[78.8-95.5]* 
89.1 (57/64) 
[78.8-95.5]* 
1 
75 (15/20) 
[50.9-91.3]* 
75 (15/20) 
[50.9-91.3]* 
1 
95.5 (42/44) 
[84.5-99.4]* 
95.5 (42/44) 
[84.5-99.4]* 
1 
Concordant (%) 
80.7 (71/88) 
[72.4-88.9] 
79.5 (70/88) 
[71.1-88.0] 
1 
67.9 (19/28) 
[47.7-84.1]* 
64.3 (18/28) 
[46.5-82.0] 
1 
86.7 (52/60) 
[75.4-94.1]* 
86.7 (52/60) 
[75.4-94.1]* 
1 
Discordant (%) 
12.5 (11/88) 
[5.6-19.4] 
14.8 (13/88) 
[7.4-22.2] 
0.5 
10.7 (3/28) 
[2.3-28.2] 
17.9 (5/28) 
[6.1-36.9] 
0.5 
13.3 (8/60)  
[5.9-24.6]* 
13.3 (8/60)  
[5.9-24.6]* 
1 
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Figure captions: 
 
Figure 1. Study flowchart and diagnosis of each organ group with post-mortem MR 
imaging at 1.5-T, 3-T and classical autopsy. AN: abnormal examination findings, N: 
normal examination findings, ND: non-diagnostic examination. The proportion of non-
diagnostic cases at classical autopsy was significantly higher for the brain as 
compared to all other organ groups, while in the majority of fetuses, MR imaging with 
1.5-T and 3-T was diagnostic for the brain.  
 
Figure 2. Tissue contrast comparison at 1.5-T and 3-T post-mortem MR imaging 
showing a significantly increased contrast with 3-T as compared with 1.5-T MR 
imaging for 9 out of the 14 studied ROI. The error bars are interquartile range (P25-
75). ROI: region of interest; GM: grey matter; Thal: thalamus; WM: white matter; Cart: 
cartilage; Musc: muscle; BP: blood pool; Myo: myocardium; Peff: pericardial effusion; 
PI: pleural effusion; Adre: adrenals; Cort: renal cortex; Pelvis: renal pelvis; *: p<0.05. 
 
Figure 3. MRI at 1.5 T and 3-T of a fetus with Trisomy 13 and in utero fetal death at 
41 weeks’ gestation. T2-weighted turbo spin-echo image in a coronal view at the level 
of thoracic and abdominal structures with (A) 1.5 T and (B) 3-T showing better signal-
to-noise ratio at 3-T than 1.5 T. Acquisition parameters for 1.5 T: Slice thickness =2.0 
mm; no intersection gap; TR/TE = 6800ms / 127ms; Voxel resolution = 0.8x0.5x2.0 
mm3). Acquisition parameters for 3-T: Slice thickness =1.3 mm; no intersection gap; 
TR/TE = 5230ms / 80ms; Voxel resolution = 0.5x0.6x1.3 mm3). 
 
Figure 4. Correlation between diagnostic error and gestational age for each organ 
group and for both 1.5-T and 3-T MR imaging, showing significant inverse correlation 
for all organs with gestational age, except for the brain. The dotted line is the 
regression line for fetuses with 1.5-T and the solid line for 3-T MR imaging. 
 
Figure 5. Box plots of the diagnostic error between 1.5-T and 3-T post-mortem MR 
imaging showing (A) for fetuses at < 20 weeks of gestation significantly lower 
diagnostic error for all organ groups except for the brain and (B) for fetuses at ≥ 20 
weeks of gestation significantly lower diagnostic error for all organ groups except for 
the brain and face. The solid line within each box corresponds to the median. Upper 
and lower bars of boxes correspond to the first and third quartiles, respectively. Two 
vertical lines (whiskers) outside the box extend to the smallest and largest 
observations within 1.5 times the interquartile range of quartiles (interquartile range 
extends from the third quartile to first quartile). Circles are outliers corresponding to 
some false positive and false negative cases. 
 
Figure 6. MRI at 1.5 T and 3-T of a fetus with left heterotaxia, terminated at 17 weeks’ 
gestation. T2-weighted turbo spin-echo image in an axial view at the level of the 4-
chamber view with MRI at (A) 1.5 T showing a normal situs of the heart but hardly 
showing the cardiac anatomy and (B) 3-T showing an intraventricular septal defect 
(arrow). Acquisition parameters for 1.5 T: Slice thickness =1.5 mm; no intersection 
gap; TR/TE = 5680ms / 109ms; Voxel resolution = 0.8x0.5x1.5 mm3). Acquisition 
parameters for 3-T: Slice thickness =0.8 mm; no intersection gap; TR/TE = 3620ms / 
80ms; Voxel resolution = 0.5x0.6x0.8 mm3).  
 
Figure 7. MRI at 1.5-T and 3-T of a fetus with VACTERL association terminated at 36 
weeks’ gestation. T2-weighted turbo spin-echo image in an coronal view with MRI 1.5-
T (A) and 3-T (B) both showing dilated bowels with a mixture of amniotic liquid with 
meconium suggesting a distal obstruction and a pelvic kidney (*). Moreover, 3-T shows 
clearly the cervical hemivertebrae (arrow), which can be only suspected on the 1.5-T 
MRI. Acquisition parameters for 1.5 T: Slice thickness =2.0 mm; no intersection gap; 
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TR/TE = 11000ms / 127ms; Voxel resolution = 0.8x0.5x2.0 mm3). Acquisition 
parameters for 3-T: Slice thickness =1.5 mm; no intersection gap; TR/TE = 6800ms / 
80ms; Voxel resolution = 0.5x0.6x1.5 mm3).  
 
Figure 8. MRI at 1.5-T and 3-T of a fetus with congenital CMV infection inducing 
severe brain lesions terminated at 33 weeks’ gestation. T2-weighted turbo spin-echo 
image in an axial view with MRI 1.5-T (A) and 3-T (B) both showing periventricular 
leucomalacia with microcalcifications (arrow), periventricular calcifications (open 
arrow), intraventricular septum (asterix) and gyration abnormalities (arrow head). 
Acquisition parameters for 1.5 T: Slice thickness =2.0 mm; no intersection gap; TR/TE 
= 11800ms / 100ms; Voxel resolution = 0.8x0.5x2.0 mm3. Acquisition parameters for 
3-T: Slice thickness =1.5 mm; no intersection gap; TR/TE = 15690ms / 80ms; Voxel 
resolution = 0.5x0.6x1.5 mm3.  
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